Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RGTA in the Treatment of Jaw Cysts
ChiCTR2400093663Phase 4Recruiting
- Sponsor
- School and Hospital of Stomatology, China Medical University
- Start
- Dec 2024
- Modality
- Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of RGTA in jaw cyst (2 arms), sponsored by School and Hospital of Stomatology, China Medical University. Primary endpoint: Evaluation of osteogenic effect. Started Dec 2024; status: recruiting.
02
Drugs
RGTA
03
Conditions
jaw cyst
Beyond the preview
Go deeper on ChiCTR2400093663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093663.